Donor specific immunomodulatory cells (DSIMC) clinical trials

Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression

This study is testing a new cell treatment for people having a liver transplant. It aims to see if this treatment can help reduce the need for strong anti-rejection medicines, making it safer and easier for patients after their surgery.